M&A
Drugmaker Lupin acquires UK-based Renascience Pharma for Rs.135-Cr
Lupin Healthcare (UK) Ltd, a wholly-owned subsidiary of the Mumbai-based, listed drug maker Lupin Ltd, has acquired 100% stake in UK-based Renascience Pharma for GBP 12.3 million (around INR 135 crore). Renascience will function as Lupin’s subsidiary.Renascience is the sole supplier for branded injectable cephalosporins for infectious diseases, a topical treatment for ear pain and a branded quinazoline-like diuretic for cardiovascular and renal indications in the UK market.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
